Limb Girdle Muscular Dystrophy Market: By Dystrophy Type, By Treatment Type, By End-user, and Region Forecast 2020-2031

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Limb Girdle Muscular Dystrophy Market Size, Share, Growth, Trends, and Global Industry Analysis: By Dystrophy Type (Limb-girdle Muscular Dystrophy Type-A and Limb-girdle Muscular Dystrophy Type-B), By Treatment Type (Symptomatic Treatments, Molecular & Gene Therapy, Stem-Cell Transplantation, Exon Skipping, and Others), By End-user (Hospital, Ambulatory Centres, and Others), and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Limb Girdle Muscular Dystrophy Market size was valued at US$ XX million in 2023 and is poised to grow at an 4.9% CAGR from 2024 to 2030. Limb-Girdle Muscular Dystrophy (LGMD) is a clinically heterogeneous group of disorders presenting a spectrum of disease severity ranging from severe childhood-onset muscular dystrophy to adult-onset dystrophy including both dominant and recessive forms. The increasing prevalence along with increasing expenditure on healthcare will drive the demand for limb-girdle muscular dystrophy treatment. Additionally, growing R&D activities and the development of treatment for such a rare disease contribute to market revenue growth. Moreover, several pipeline drugs such as SRP-9003, GenPHSat, BBP-418 (ribitol), and LION-101 are expected to receive FDA approval and be launched in the market in the coming years, boosting the market.

Furthermore, growing awareness among the population and increasing government initiatives for disease awareness are raising the demand for preventive treatment, boosting the market. However, the lack of existed molecules in the market and limited number of drugs in the pipeline are the factors expected to restrain the market during the forecast period. Fundraising from public and private organizations and development of novel molecules for the limb girdle muscular dystrophy treatment are anticipated to create lucrative opportunity for the companies in the near future. However, Artificial Intelligence (AI) has the potential to revolutionize the LGMD treatment market by significantly impacting the drug development and design process, offering a glimmer of hope for future therapeutic breakthroughs.

Limb Girdle Muscular Dystrophy Treatment Market Key Players:
  • In February 2022, Asklepios BioPharmaceutical, Inc., a subsidiary of Bayer AG, announced that the European Commission (EC) granted orphan drug status to AB-1003 (also known as LION-101) for the treatment of limb-girdle muscular dystrophy (LGMD)

summary download arrow Download Free Sample

Limb Girdle Muscular Dystrophy Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

4.9%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Global Limb Girdle Muscular Dystrophy Market Dynamics

Major market players, such as established pharmaceutical companies, are launching new drugs after FDA approval, and contribute to the market growth by having strong brand recognition, extensive research & development (R&D) investments, and increased investor confidence. These factors help to quickly deliver new FDA-approved drugs to patients and attract investments to the market, fueling further development and innovation. Moreover, AI can perform in-silico simulations to virtually screen millions of candidate molecules and identify those with the most promising therapeutic potential for LGMD. This significantly reduces the time and resources needed for traditional drug discovery processes. AI is paving the way for personalized treatment plans that target the underlying cause of their LGMD subtype by analyzing individual patient genetic data to predict their response to specific therapies.

Limb Girdle Muscular Dystrophy Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market CAGR

4.9%

By Dystrophy Type

  • Limb-girdle Muscular Dystrophy Type-A (Dominant)
  • Limb-girdle Muscular Dystrophy Type-B (Recessive)

By Treatment

  • Symptomatic Treatments
  • Molecular & Gene Therapy
  • Stem-Cell Transplantation
  • Exon Skipping
  • Others

By End User

  • Hospital
  • Ambulatory Centers
  • Others

Key Features of the Report

  • The limb girdle muscular dystrophy market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2023 is the base year and 2030 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Limb Girdle Muscular Dystrophy Market Introduction 
2.1.Global Limb Girdle Muscular Dystrophy Market  - Taxonomy
2.2.Global Limb Girdle Muscular Dystrophy Market  - Definitions
2.2.1.Dystrophy Type
2.2.2. Treatment Type
2.2.3.End User
2.2.4.Region
3.Global Limb Girdle Muscular Dystrophy Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Limb Girdle Muscular Dystrophy Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Limb Girdle Muscular Dystrophy Market  By Dystrophy Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Limb-girdle Muscular Dystrophy Type-A (Dominant)
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Limb-girdle Muscular Dystrophy Type-B (Recessive)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Limb Girdle Muscular Dystrophy Market  By Treatment Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Symptomatic s
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Molecular & Gene Therapy
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Stem-Cell Transplantation
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Exon Skipping
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Limb Girdle Muscular Dystrophy Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospital
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Limb Girdle Muscular Dystrophy Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Limb Girdle Muscular Dystrophy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Dystrophy Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Limb-girdle Muscular Dystrophy Type-A (Dominant)
9.1.2.Limb-girdle Muscular Dystrophy Type-B (Recessive)
9.2.    Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Symptomatic s
9.2.2.Molecular & Gene Therapy
9.2.3.Stem-Cell Transplantation
9.2.4.Exon Skipping
9.2.5.Others
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital
9.3.2.Ambulatory Centers
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Limb Girdle Muscular Dystrophy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Dystrophy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Limb-girdle Muscular Dystrophy Type-A (Dominant)
10.1.2.Limb-girdle Muscular Dystrophy Type-B (Recessive)
10.2.    Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Symptomatic s
10.2.2.Molecular & Gene Therapy
10.2.3.Stem-Cell Transplantation
10.2.4.Exon Skipping
10.2.5.Others
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital
10.3.2.Ambulatory Centers
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Limb Girdle Muscular Dystrophy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Dystrophy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Limb-girdle Muscular Dystrophy Type-A (Dominant)
11.1.2.Limb-girdle Muscular Dystrophy Type-B (Recessive)
11.2.    Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Symptomatic s
11.2.2.Molecular & Gene Therapy
11.2.3.Stem-Cell Transplantation
11.2.4.Exon Skipping
11.2.5.Others
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital
11.3.2.Ambulatory Centers
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Limb Girdle Muscular Dystrophy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Dystrophy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Limb-girdle Muscular Dystrophy Type-A (Dominant)
12.1.2.Limb-girdle Muscular Dystrophy Type-B (Recessive)
12.2.    Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Symptomatic s
12.2.2.Molecular & Gene Therapy
12.2.3.Stem-Cell Transplantation
12.2.4.Exon Skipping
12.2.5.Others
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital
12.3.2.Ambulatory Centers
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Limb Girdle Muscular Dystrophy Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Dystrophy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Limb-girdle Muscular Dystrophy Type-A (Dominant)
13.1.2.Limb-girdle Muscular Dystrophy Type-B (Recessive)
13.2.    Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Symptomatic s
13.2.2.Molecular & Gene Therapy
13.2.3.Stem-Cell Transplantation
13.2.4.Exon Skipping
13.2.5.Others
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital
13.3.2.Ambulatory Centers
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Jubilant Cadista Pharmaceuticals Inc.
14.2.2.Aden Pharmaceuticals Private Limited
14.2.3.ML Bio Solutions Inc.
14.2.4.Genethon
14.2.5.Sarepta Therapeutics Inc.
14.2.6.Asklepios Biopharmaceutical Inc.
14.2.7.Atamyo Therapeutics
14.2.8.Simone Spuler MD
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Jubilant Cadista Pharmaceuticals Inc.
  • Aden Pharmaceuticals Private Limited
  • ML Bio Solutions Inc.
  • Genethon
  • Sarepta Therapeutics Inc.
  • Asklepios Biopharmaceutical Inc.
  • Atamyo Therapeutics
  • Simone Spuler MD

Related Industry Reports

Research Use Only Market

Intraoperative Radiation Therapy Market

Extracorporeal Membrane Oxygenation Machine Market

Chronic Refractory Gout Pharmaceuticals Market